British American Tobacco Industries p.l.c. Common Stock ADR (BTI)
Stock · NYSE · Health Care
$60as of 10/16/2026
Price chart
Active signals
BTI Signal Track Record
How signals performed across all stocks →What BTI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | +2.6% | 59% | September 1, 2026 |
| Bollinger Band BreakoutActive now | 22 | -0.7% | 41% | July 16, 2026 |
| Bollinger Band Breakdown | 20 | +1.0% | 50% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 14 | -2.2% | 36% | August 26, 2026 |
| Any 20-session window (baseline) | +0.8% | 54% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About BTI
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated products, which consists of a battery-powered device and a plant-based substance consumable that is heated; modern oral products, such as nicotine pouches; combustibles,…
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Employees
- 47,797
- Website
- www.bat.com/
Fundamentals
- 1-day range
- $58.98$60.02
- Market cap
- $127.32B
- P/E (trailing)
- 14.22
- P/E (forward)
- 11.45
- EPS (trailing)
- $2.95
- Dividend yield
- 8.91%
- Beta
- 0.77
- Avg. volume
- 4.67M
- Ex-dividend date
- December 29, 2026
- Dividend pay date
- February 8, 2027
Forecasts
6 analyst ratings
British American Tobacco Industries p.l.c. Common Stock ADR Competitors
Chosen by industry and closest market cap.
- BTIBritish American Tobacco Industries p.l.c. Common Stock ADR$60▲ 3.45%Market cap $127.32BP/E 14.22$3,718$5,004
- MOAltria Group Inc.$75.11▲ 1.72%Market cap $113.13BP/E 15.48$54.7$77.06
- DFTXDefinium Therapeutics Inc. Common Shares$32.1▼ 6.30%Market cap $5.03BP/E —$10.47$49.7
- RLXRLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share$1.7▼ 0.58%Market cap $3.08BP/E 14.19$1.65$2.6
- RGCRegencell Bioscience Holdings Limited Ordinary Shares$9.59▲ 0.74%Market cap $2.70BP/E —$4.51$69
- TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.01▼ 2.82%Market cap $1.73BP/E —$7.82$12.93
- CRONCronos Group Inc. Common Share$3.21▲ 0.31%Market cap $1.16BP/E 16.88$3.23$4.99
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BTI British American Tobacco Industries p.l.c. Common Stock ADR | $127.32B | 14.22 | $60 | ▲ 3.45% | $3,718$5,004 |
| MO Altria Group Inc. | $113.13B | 15.48 | $75.11 | ▲ 1.72% | $54.7$77.06 |
| DFTX Definium Therapeutics Inc. Common Shares | $5.03B | — | $32.1 | ▼ 6.30% | $10.47$49.7 |
| RLX RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share | $3.08B | 14.19 | $1.7 | ▼ 0.58% | $1.65$2.6 |
| RGC Regencell Bioscience Holdings Limited Ordinary Shares | $2.70B | — | $9.59 | ▲ 0.74% | $4.51$69 |
| TRLV Trulieve Cannabis Corp. Subordinate Voting Shares | $1.73B | — | $10.01 | ▼ 2.82% | $7.82$12.93 |
| CRON Cronos Group Inc. Common Share | $1.16B | 16.88 | $3.21 | ▲ 0.31% | $3.23$4.99 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CGDV Has Been A Winner In My Portfolio, And I Think It Continues, Here's WhySeekingAlpha · 10/9/2026
- Big Yields Are Easy to Find. These 4 Dividend Stocks Have Something BetterYahoo · 10/8/2026
- 5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go WrongYahoo · 10/7/2026
- 3 Dividend Stocks Worth Buying Near Their 52-Week LowsYahoo · 10/6/2026
- British American Tobacco: The Market Underestimates How Big Velo Can BecomeSeekingAlpha · 10/6/2026
- BTI: This Retracement Hands Income Investors A Fresh Opening Yielding 6.31%SeekingAlpha · 10/5/2026
- British American Tobacco: Rich Dividends And Diversified Nicotine Assets - Competition/Legal Risks AheadSeekingAlpha · 10/3/2026
- British American Tobacco p.l.c. (BTI) Analyst/Investor Day TranscriptSeekingAlpha · 10/2/2026
- 'U.S. Regulators Plan Major Move To Speed Authorizations Of Vapes, Tobacco Pouches; Move Comes Despite Lawmakers Voicing Concern About Recent Flavor Approvals' - WSJ Exclusivebenzinga · 9/23/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 318.25M
- Total value held
- $18.23B
- Institutional holders
- 863
- Unknown48.82M
- Unknown36.69M
- Unknown30.96M
- Unknown27.68M
- Unknown19.15M
- Unknown9.74M
- Unknown9.69M
- Unknown7.71M
- Unknown5.20M
- Unknown4.65M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BTI ADRs Gain Attention Amid Dividend and Industry News
BTI ADRs have been in focus as European equities traded higher in the U.S., and the company’s high dividend yield of 8.91% keeps it in the conversation with other high‑yield stocks such as Verizon, Pfizer and Realty Income. Analysts note that the South African illicit trade and ongoing buybacks could influence BTI’s investment case. The firm’s dividend policy is also compared to Philip Morris’s recent 8.8% increase, highlighting a broader industry trend toward higher payouts.
BTI ADRs Gain Attention Amid Dividend and Industry News. BTI ADRs have been in focus as European equities traded higher in the U.S., and the company’s high dividend yield of 8.91% keeps it in the conversation with other high‑yield stocks such as Verizon, Pfizer and Realty Income. Analysts note that the South African illicit trade and ongoing buybacks could influence BTI’s investment case. The firm’s dividend policy is also compared to Philip Morris’s recent 8.8% increase, highlighting a broader industry trend toward higher payouts.